New Drug Combination Offers Hope for Aggressive KRAS-Mutated Lung Cancer A novel therapeutic approach combining ERBB inhibitors with Aurora kinase inhibitors is demonstrating significant promise in treating KRAS-mutated lung adenocarcinoma, …
Tag: